Marion Dorsch und Chief Scientific Officer - Info zur Person

(1 - 27 von 36

)

Blueprint Medicines Announces Appointment of Marion Dorsch ...Nextech Invest

www.nextechinvest.com

Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly ...

Blueprint Medicines names Marion Dorsch, Ph.D. as Chief Scientific...

thefly.com

Blueprint Medicines announced that Marion Dorsch, Ph.D., will succeed Christoph Lengauer, Ph.D., MBA, as Chief Scientific Officer, effective ...

An Open Letter to the BioPharma Community - Massachusetts...

www.massbio.org

VP Strategy and External Innovation Johnson & Johnson, Janssen Research and Development. Marion Dorsch Chief Scientific Officer Blueprint ...

Blueprint Medicines names chief scientific officer replacement | S&P...

www.spglobal.com

Marion Dorsch is replacing Christoph Lengauer as Blueprint Medicines Corp.'s chief scientific officer, starting Nov Lengauer is transitioning to the newly ...

LinkedIn: Marion Dorsch – Chief Scientific Officer – Blueprint Medicines ...de.linkedin.com › marion-dorsch-a33a157

Sehen Sie sich das Profil von Marion Dorsch auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 6 Jobs sind im Profil von Marion Dorsch aufgelistet.

fopindia, Author at FOP India

fopindia.org

— ... oral inhibitor of mutant ALK2, the underlying cause of FOP,” said Marion Dorsch, Ph.D., Chief Scientific Officer of Blueprint Medicines. › author › fopi...

Blueprint Medicines Announces Appointment of Marion ...PR Newswire

www.prnewswire.com

— Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, ...

Blueprint Medicines Announces R&D Leadership Transitions

www.prnewswire.com

— In addition, Marion Dorsch, Ph.D., has notified the company of her intention to resign as the company's Chief Scientific Officer to pursue ... › blu...

Marion Dorsch - BiographyMarket Screener

www.marketscreener.com

Currently, Marion Dorsch holds the position of Chief Scientific Officer of Blueprint Medicines Corp. In her past career Dr. Dorsch was Vice ...

Marion Dorsch - Biografie

ch.marketscreener.com

Currently, Marion Dorsch occupies the position of Chief Scientific Officer of Blueprint Medicines Corp. In the past she occupied the position of Vice...

2nd Dana-Farber's Chemical Biology SymposiumHarvard University

careernavigator.gradeducation.hms.harvard.edu

— Marion Dorsch , Ph.D., Chief Scientific Officer, Blueprint Medicines. “Unlocking the full potential of kinase medicines: highly selective ...

Marion Dorsch - Chief Scientific Officer - Blueprint Medicines | LinkedIn

www.linkedin.com

View Marion Dorsch's profile on LinkedIn, the world's largest professional community. Marion has 6 jobs listed on their profile. See the complete profile on ...

BPMC Profile | Blueprint Medicines Corporation Stock - Yahoo Finance

finance.yahoo.com

Name, Title, Pay, Exercised, Age. Mr. Daniel S. Lynch, Exec. Chairman, k, N /A, 59. Mr. Jeffrey W. Albers, CEO, Pres & Director, k, N/A, 46. Mr. Alexis Borisy, Co-Founder & Director, N/A, N/A, 45. Dr. Marion Dorsch Ph.D. Chief Scientific Officer, k, N/A, 52. Ms. Tracey L. Mccain Esq. Chief Legal Officer and ...

Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as...

m.insidertracking.com

Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a ...

Edited Transcript of BPMC earnings conference call or presentation

finance.yahoo.com

Dr. Marion Dorsch, our Chief Scientific Officer, will discuss our foundational preclinical data for BLU-782, and Mike Landsittel, our Vice ...

citybizlist : Boston : Blueprint Medicines Appoints Marion Dorsch,...

boston.citybizlist.com

Blueprint Medicines Appoints Marion Dorsch, Ph.D. as Chief Scientific Officer Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in ...

Blueprint Medicines Announces R&D Leadership Transitionsfinance.yahoo.com › news › blueprint-medicines-an...

finance.yahoo.com

· Marion Dorsch, Ph.D., Chief Scientific Officer, to depart the company --. CAMBRIDGE, Mass., Jan. 11, PRNewswire/ -- Blueprint ...

Marion Dorsch Salary Infomation | ERI Economic Research Institute

www.erieri.com

Marion Dorsch, the Chief Scientific Officer of Blueprint Medicines Corp, made $2,882,288 in total compensation during 2016, according to salary benchmarking...

Marion Dorsch Net Worth & Insider TradesBenzinga

www.benzinga.com

The current estimated net worth of Blueprint Medicines Corp's Chief Scientific Officer, Marion Dorsch, is estimated to be about $6.57M . Marion Dorsch owns ...

Marion Dorsch Net Worth Strike.Marketstrike.market › Key Executives › Marion Dorsch

strike.market

· Murray Senior Vice President of Technical Operations; Dr. Fouad Namouni Pres of R&D; Dr. Marion Dorsch Chief Scientific Officer; Mr. Alexis A.

Atavistik Bio Announces Publication Describing ...Drug Development & Delivery

drug-dev.com

Marion Dorsch, PhD, President and Chief Scientific Officer at Atavistik Bio, added “It's very exciting to share details of our foundational technology with ...

BLU-945 Clinical Trial Is Open for Triple Mutant EGFREGFR Resisters

egfrcancer.org

— ... EGFR-targeted therapies across multiple treatment lines,” said Marion Dorsch, Ph.D., Chief Scientific Officer of Blueprint Medicines.

BLU 554 – Drug Approvals International

drugapprovalsint.com

Marion Dorsch. Chief Scientific Officer at Blueprint Medicines. Chris De Savi. Director of Medicinal Chemistry at Blueprint Medicines. Blueprint Medicines Logo . Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients ...

Tony Fretton
Wilhelm Ripl

Person "Dorsch" (4)
Vorname "Marion" (33407)
Name "Dorsch" (789)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Marion Dorsch und Chief Scientific Officer Person-Info

Blueprint Medicines Announces Appointment of Marion Dorsch ...Nextech Invest

Blueprint Medicines names Marion Dorsch, Ph.D. as Chief Scientific...

An Open Letter to the BioPharma Community - Massachusetts...

Blueprint Medicines names chief scientific officer replacement | S&P...

LinkedIn: Marion Dorsch – Chief Scientific Officer – Blueprint Medicines ...de.linkedin.com › marion-dorsch-a33a157

fopindia, Author at FOP India

Blueprint Medicines Announces Appointment of Marion ...PR Newswire

Blueprint Medicines Announces R&D Leadership Transitions

Marion Dorsch - BiographyMarket Screener

Marion Dorsch - Biografie

2nd Dana-Farber's Chemical Biology SymposiumHarvard University

Marion Dorsch - Chief Scientific Officer - Blueprint Medicines | LinkedIn

BPMC Profile | Blueprint Medicines Corporation Stock - Yahoo Finance

Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as...

Edited Transcript of BPMC earnings conference call or presentation

citybizlist : Boston : Blueprint Medicines Appoints Marion Dorsch,...

Blueprint Medicines Announces R&D Leadership Transitionsfinance.yahoo.com › news › blueprint-medicines-an...

Marion Dorsch Salary Infomation | ERI Economic Research Institute

Marion Dorsch Net Worth & Insider TradesBenzinga

Marion Dorsch Net Worth Strike.Marketstrike.market › Key Executives › Marion Dorsch

Atavistik Bio Announces Publication Describing ...Drug Development & Delivery

BLU-945 Clinical Trial Is Open for Triple Mutant EGFREGFR Resisters

BLU 554 – Drug Approvals International

Blueprint Medicines Presents Foundational Preclinical Data Supporting...

Blueprint Medicines Corp (Form: 8-K, Received: :42:37)

Media Center - Thirdrockventures

Speakers

Alle Infos zum Namen "Marion Dorsch"